Zhang, T., Xu, J., Yin, J., Gao, Y., Zheng, H., Fu, B., Sun, J., Xu, Z., Tu, S., Mao, Y., Wen, W., Qu, B., You, L., Xue, Z., Sun, X., Cao, D., Feng, J., Hu, M., He, F. (2025). SHR-A1811, a novel anti-HER2 antibody–drug conjugate with optimal drug-to-antibody ratio, efficient tumor killing potency, and favorable safety profiles. PLoS ONE. https://doi.org/10.1371/journal.pone.0326691